title: [Prevention and management of appetite loss during cancer chemotherapy].
abstract: Appetite loss during cancer chemotherapy may lead to malnutrition and a decreased quality of life. To overcome this problem, evidence-based guidelines have been established for chemotherapy-induced emesis and mucositis. However, unsolved issues such as taste alimentation remain. Since the clinical picture of appetite loss is complex, individual management strategies depending on the type of the disease and treatment are required.
authors.affiliation: Division of Clinical Oncology,Chiba Cancer Center.
authors.forename: Hideki
authors.initials: H
authors.lastname: Tsujimura
authors.forename: Mitsugi
authors.initials: M
authors.lastname: Yamada
authors.forename: Eri
authors.initials: E
authors.lastname: Asako
authors.forename: Yukako
authors.initials: Y
authors.lastname: Kodama
authors.forename: Tsuneo
authors.initials: T
authors.lastname: Sato
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Nabeya
mesh_terms: D000855:Anorexia / Q000517:prevention & control* / Q000628:therapy; D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D052016:Mucositis / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control; D009369:Neoplasms / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D011788:Quality of Life; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control
chemical_list: D000932:Antiemetics; D000970:Antineoplastic Agents